Zobrazeno 1 - 10
of 1 102
pro vyhledávání: '"Anagrelide"'
Publikováno v:
Case Reports in Dermatological Medicine. 3/27/2018, p1-4. 4p.
Autor:
Petrides, Petro E.1, Schoergenhofer, Christian2, Widmann, Rudolf3, Jilma, Bernd2 Bernd.jilma@meduniwien.ac.at, Klade, Christoph S.3
Publikováno v:
Clinical Pharmacology in Drug Development. Feb2018, Vol. 7 Issue 2, p123-131. 9p.
Publikováno v:
ARS Medica Tomitana. Feb2018, Vol. 24 Issue 1, p46-54. 9p.
Publikováno v:
European Journal of Case Reports in Internal Medicine (2024)
Anagrelide is a medication primarily used to manage thrombocytosis, an abnormal increase in platelet levels in the blood. It is often prescribed for patients with myeloproliferative disorders, such as essential thrombocythaemia (ET). Given the height
Externí odkaz:
https://doaj.org/article/fb172816d67741c891a7982ae9d5ad22
Autor:
Mela Osorio, María J.1, Ferrari, Luciana1, Goette, Nora P.2, Gutierrez, Marina I.3, Glembotsky, Ana C.2, Maldonado, Ana C.3, Lev, Paola R.2, Alvarez, Clarisa4, Korin, Laura2, Marta, Rosana F.2, Molinas, Felisa C.2, Heller, Paula G.2
Publikováno v:
European Journal of Haematology. Apr2016, Vol. 96 Issue 4, p435-442. 8p.
Autor:
Troy, Steven1, Parks, Virginia2, Purkayastha, Jaideep3, Gossart, Sophie2, Goodman, Daniel B.4, Achenbach, Heinrich5, Armstrong, Martin6, Martin, Patrick T.1
Publikováno v:
Pharmacology Research & Perspectives. Dec2014, Vol. 2 Issue 6, pn/a-N.PAG. 15p.
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 9, p 4811 (2024)
Melanoma, the deadliest type of skin cancer, has a high propensity to metastasize to other organs, including the brain, lymph nodes, lungs, and bones. While progress has been made in managing melanoma with targeted and immune therapies, many patients
Externí odkaz:
https://doaj.org/article/8e51b05005aa4ce68e8217ac7c8ffa0d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical Case Reports, Vol 11, Iss 4, Pp n/a-n/a (2023)
Abstract Pericardial effusion leading to cardiac tamponade can occur due to a multitude of etiologies, one of which is medication adverse effects. In patients with comorbid conditions, this can prove to be a challenge in its co‐management along wit
Externí odkaz:
https://doaj.org/article/b5d2f7e6ff414b9698c4bdd74e163988
Autor:
Ja Min Byun, Ho Young Kim, Seung-Hyun Nam, Ho-Jin Shin, Seulki Song, Jinny Park, Sang Hoon Han, Yong Park, Young Jin Yuh, Yeung-Chul Mun, Young Rok Do, Sang Kyun Sohn, Sung Hwa Bae, Dong-Yeop Shin, Sung-Soo Yoon
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
As the discussion of first-line anagrelide treatment is ongoing, we aimed to prospectively examine the efficacy and safety of anagrelide in cytoreduction therapy-naïve high risk essential thrombocythemia (ET) patients in Korea. Seventy patients from
Externí odkaz:
https://doaj.org/article/053c6a7d2e1f40f3947f13cdf422dbf4